cyc 202 has been researched along with Hormone-Dependent Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helenius, MA; Jänne, OA; Linja, MJ; Manni, V; Sahu, B; Visakorpi, T; Waltering, KK | 1 |
| Gritsch, D; Komina, O; Maurer, M; Węsierska-Gądek, J; Zulehner, N | 1 |
| Chu, B; Mohapatra, S; Pledger, WJ; Zhao, X | 1 |
3 other study(ies) available for cyc 202 and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Topics: Androgens; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Gene Expression Profiling; Humans; Male; Neoplasms, Hormone-Dependent; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Purines; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Roscovitine | 2009 |
Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinases; Dichlororibofuranosylbenzimidazole; Drug Synergism; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent; Phosphorylation; Purines; RNA Polymerase II; Roscovitine; Tamoxifen; Tumor Suppressor Protein p53 | 2011 |
Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.
Topics: 2-Aminopurine; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinases; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Protein Kinase Inhibitors; Proteins; Purines; Roscovitine; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2005 |